Impel Pharmaceuticals Inc.(NasdaqGM:IMPL) dropped from S&P TMI Index
IPI Legacy Liquidation Co
Equities
IMPL
US45258K1097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+36.73% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+27.49% | 12.08B | |
+22.40% | 11.94B |